PyInvesting

Market research

214390.KO Kyongbo Pharmaceutical Co., Ltd

KO KRW Healthcare

Latest close

4,850.00 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
119B
P/E ratio
23.79
Analyst target
Not available
Dividend yield
1.0%
Beta
0.31

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Kyongbo Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 6.3% above its 200 day moving average.

From a valuation standpoint, the stock is 83.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.

Kyongbo Pharmaceutical Co., Ltd's total revenue sank by 0.1% to $49B since the same quarter in the previous year.

Its net income has increased by 118.5% to $337M since the same quarter in the previous year.

Finally, its free cash flow grew by 161.5% to $3B since the same quarter in the previous year.

Based on the above factors, Kyongbo Pharmaceutical Co., Ltd gets an overall score of 4/5.